Idalopirdine

Idalopirdine
Systematic (IUPAC) name
2-(6-Fluoro-1H-indol-3-yl)-N-(3-(2,2,3,3-tetrafluoropropoxy)benzyl)ethanamine
Identifiers
CAS Number 467459-31-0 N
ATC code None
ChemSpider 19878969 N
ChEMBL CHEMBL3286580
Synonyms Lu-AE-58054
Chemical data
Formula C20H19F5N2O
Molar mass 398.37 g/mol
 NYesY (what is this?)  (verify)

Idalopirdine (INN) (code names Lu AE58054, SGS-518) is a potent and selective 5-HT6 receptor antagonist under development by Lundbeck as an augmentation therapy for the treatment of cognitive deficits associated with Alzheimer's disease and schizophrenia.[1][2] As of October 2013 it is in phase III clinical trials.[2]

See also

References

External links


This article is issued from Wikipedia - version of the Saturday, April 02, 2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.